Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC007969 | Panoply™ Human KCNJ3 Knockdown Stable Cell Line | Inquiry |
| CSC-SC007969 | Panoply™ Human KCNJ3 Over-expressing Stable Cell Line | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD08426Z | Human KCNJ3 adenoviral particles | Inquiry |
| LV15995L | human KCNJ3 (NM_002239) lentivirus particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHH323287 | shRNA set against Human KCNJ3 (NM_002239.3) | Inquiry |
| SHH323291 | shRNA set against Mouse KCNJ3 (NM_008426.1) | Inquiry |
| SHH323295 | shRNA set against Rat KCNJ3 (NM_031610.3) | Inquiry |
| SHL191226 | shRNA set against Rat Kcnj3(NM_031610.3) | Inquiry |
| SHL191244 | shRNA set against Mouse Kcnj3(NM_008426.1) | Inquiry |
| SHW005898 | shRNA set against Chicken KCNJ3 (NM_205404) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CDFR012766 | Rat Kcnj3 cDNA Clone(NM_031610.3) | Inquiry |
| MiUTR1M-06237 | KCNJ3 miRNA 3'UTR clone | Inquiry |
| MiUTR1R-02823 | KCNJ3 miRNA 3'UTR clone | Inquiry |
| MiUTR3H-04197 | KCNJ3 miRNA 3'UTR clone | Inquiry |
| CDCB167373 | Chicken KCNJ3 ORF Clone (NM_205404) | Inquiry |
| CDCB195509 | Rabbit KCNJ3 ORF clone (XM_002712182.2) | Inquiry |
| CDCL123099 | Human Kcnj3 ORF clone (NM_008426.1) | Inquiry |
| CDCR379769 | Rat Kcnj3 ORF Clone(NM_031610.3) | Inquiry |
| CDCS410701 | Human KCNJ3 ORF Clone (BC022495) | Inquiry |
Recent Research
KCNJ3 is an inwardly rectifying potassium channel, subfamily J, member 3. It is also known as GIRK1 and Kir3.1. It belongs to a G protein-gated inwardly rectifying potassium (GIRK) channel family that plays a crucial role in controlling neuronal excitability by hyperpolarizing the membrane and generating slow post synaptic inhibitory potentials. GIRK channel is formed by the diversity of the four subunits expressed in mammals (GIRK1-GIRK4), of which only the first three are commonly expressed in the brain.
GIRK is a G protein effector that regulates cell excitability and activity through neurotransmitters and hormones. GIRK loss-of-function can lead to excessive neuronal excitation, such as in epilepsy, whereas gain-of-function can substantially reduce neuronal activity, such as when GIRK2 is triplicated in a mouse model of Down syndrome. In humans, changes in the expression level of KCNJ3 gene are associated with schizophrenia, developmental delays, epilepsy and language impairment, and mental retardation in children.
Several studies have demonstrated a closely correlation of increased KCNJ3 expression levels, breast cancer progression and patient’s prognosis. Stringer et al observed increased levels of KCNJ3 mRNA in primary invasive breast carcinomas when compared with corresponding normal breast tissue and found KCNJ3 mRNA levels positively correlating with the amount of metastatic lymph nodes. These results were supported by a study by Brevet et al that showed a correlation between GIRK1 protein expression and lymph node metastasis, as well as reduced overall survival in patients with tumors with high GIRK1 expression. In addition, the relevance of KCNJ3 in breast cancer is further underscored by Rezania et al, who demonstrated increased motility, invasiveness and angiogenesis of KCNJ3 over-expressing MCF-7 breast cancer cells compared with controls. Ko et al performed ion channel profiling in breast cancer, they found that KCNJ3 to be down-regulated in p53 mutant breast cancer samples and up-regulated in oestrogen receptor (ER) positive tumours.
References: